This topic contains a solution. Click here to go to the answer

Author Question: Refer to Figure 13-1. Ceteris paribus, a decrease in firms' expectations of the future profitability ... (Read 143 times)

Lisaclaire

  • Hero Member
  • *****
  • Posts: 569
Refer to Figure 13-1. Ceteris paribus, a decrease in firms' expectations of the future profitability of investment spending would be represented by a movement from
 
  A) AD1 to AD2. B) AD2 to AD1. C) point A to point B. D) point B to point A.

Question 2

In a small European country, it is estimated that a 10,000 increase in capital per hour worked will increase real GDP per hour worked by 300. Based on this information, what is the slope of the per-worker production function in this range?
 
  A) 0.03 B) 3.3 C) 33.3 D) 333



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jlaineee

  • Sr. Member
  • ****
  • Posts: 380
Answer to Question 1

B

Answer to Question 2

A




Lisaclaire

  • Member
  • Posts: 569
Reply 2 on: Jun 29, 2018
Thanks for the timely response, appreciate it


Zebsrer

  • Member
  • Posts: 284
Reply 3 on: Yesterday
Excellent

 

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library